Corrected: Kentucky takes PBMs to court over 'outrageous' insulin prices

Paul Schloesser

Associate Editor

Kentucky is suing several pharmacy benefit managers, adding them to an existing suit against insulin makers and accusing them of violating multiple consumer rights laws …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Corrected: Kentucky takes PBMs to court over 'outrageous' insulin prices

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Boehringer’s updated results in HER2-mutated lung cancer impress

Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B

GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer

Scholar Rock names new CEO, adds biotech veterans in C-suite rebuild

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?

Cor­rect­ed: Ken­tucky takes PBMs to court over 'outra­geous' in­sulin prices

Associate Editor

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

Corrected: Kentucky takes PBMs to court over 'outrageous' insulin prices